Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 16, Issue 1, pp. 311-319
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 23, 2009
- Revision received September 28, 2009
- Accepted October 12, 2009
- Published first December 22, 2009.
Article Versions
- Previous version (December 22, 2009 - 06:36).
- You are viewing the most recent version of this article.
Copyright & Usage
©2010 American Association for Cancer Research.
Author Information
- Klaus Mross1,
- Martin Stefanic3,
- Daniela Gmehling1,
- Annette Frost1,
- Franziska Baas1,
- Clemens Unger1,
- Ralph Strecker2,
- Jürgen Henning2,
- Birgit Gaschler-Markefski3,
- Peter Stopfer3,
- Lothar de Rossi3 and
- Rolf Kaiser3
- Authors' Affiliations: 1Tumour Biology Center and 2Department of Radiology, Section MR-Development, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany; and 3Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
- Corresponding Author:
Klaus Mross, Tumour Biology Center, Albert-Ludwigs-Universität Freiburg, D-79106 Freiburg in Breisgau, Germany. Phone: 49-761-206-1833; Fax: 49-761-206-1832; E-mail: mross{at}tumorbio.uni-freiburg.de.
Partly presented at the European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research 2006, International Society for Magnetic Resonance in Medicine 2006, American Society of Clinical Oncology 2005, and Central European Society for Anticancer Drug Research 2005 meetings.
January 2010
Volume 16, Issue 1
Volume 16, Issue 1
Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
Jump to section
Advertisement